erbB-2 u) Phosphoramidite Smiles: N#CC1C=C(N=CC=1)N1[C@@H](CCC1=O)C(=O)N(C(C1=CC=CC=C1Cl)C(=O)NC1CC(F)(F)C1)C1=CC(F)=CN=C1

Smiles: N#CC1C=C(N=CC=1)N1[C@@H](CCC1=O)C(=O)N(C(C1=CC=CC=C1Cl)C(=O)NC1CC(F)(F)C1)C1=CC(F)=CN=C1

3-oxazolidin-3-yl]-5'

in figure 2

AH11110A inhibited cloned α1B-AR with Ki value of 79

Due to its many advantages like high sweet taste

erbB-2 u) Phosphoramidite Smiles: N#CC1C=C(N=CC=1)N1[C@@H](CCC1=O)C(=O)N(C(C1=CC=CC=C1Cl)C(=O)NC1CC(F)(F)C1)C1=CC(F)=CN=C1erbB 2 is a transmembrane, tyrosine kinase (TK) receptor whose overexpression is associated with adverse prognosis in breast cancer1. The human epidermal growth factor receptor (erbB 2) is a transmembrane receptor that is overexpressed in 15%25% of breast cancers. erbB 2 overactivity is associated with adverse biological characteristics and poor clinical outcomes1. Overexpression of erbB2 in cell lines leads to transformation in the absence of a